These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19710544)

  • 1. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy.
    Palomero-Gallagher N; Bidmon HJ; Cremer M; Schleicher A; Kircheis G; Reifenberger G; Kostopoulos G; Häussinger D; Zilles K
    Cell Physiol Biochem; 2009; 24(3-4):291-306. PubMed ID: 19710544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter receptor alterations in hepatic encephalopathy: a review.
    Palomero-Gallagher N; Zilles K
    Arch Biochem Biophys; 2013 Aug; 536(2):109-21. PubMed ID: 23466244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter receptor density changes in Pitx3ak mice--a model relevant to Parkinson's disease.
    Cremer JN; Amunts K; Graw J; Piel M; Rösch F; Zilles K
    Neuroscience; 2015 Jan; 285():11-23. PubMed ID: 25451278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy.
    Ferenci P; Riederer P; Jellinger K; Schafer DF; Jones EA
    Liver; 1988 Aug; 8(4):225-30. PubMed ID: 2843723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology.
    Butterworth RF
    Drugs; 2019 Feb; 79(Suppl 1):17-21. PubMed ID: 30706423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
    Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of excitatory and inhibitory amino acid, sigma, monoamine, catecholamine, acetylcholine, opioid, neurotensin, substance P, adenosine and neuropeptide Y receptors in human motor and somatosensory cortex.
    Jansen KL; Faull RL; Dragunow M; Leslie RA
    Brain Res; 1991 Dec; 566(1-2):225-38. PubMed ID: 1726061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the expression of neurotransmitter receptors in Parkin and DJ-1 knockout mice--A quantitative multireceptor study.
    Cremer JN; Amunts K; Schleicher A; Palomero-Gallagher N; Piel M; Rösch F; Zilles K
    Neuroscience; 2015 Dec; 311():539-51. PubMed ID: 26546471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular aspects of hepatic encephalopathy].
    Márquez-Aguirre AL; Canales-Aguirre AA; Gómez-Pinedo U; Gálvez-Gastélum FJ
    Neurologia; 2010 May; 25(4):239-47. PubMed ID: 20609302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy.
    Ferenci P; Pappas SC; Munson PJ; Henson K; Jones EA
    Hepatology; 1984; 4(2):186-91. PubMed ID: 6323295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.
    Cauli O; Llansola M; Erceg S; Felipo V
    J Hepatol; 2006 Nov; 45(5):654-61. PubMed ID: 16982110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy.
    Llansola M; Montoliu C; Agusti A; Hernandez-Rabaza V; Cabrera-Pastor A; Gomez-Gimenez B; Malaguarnera M; Dadsetan S; Belghiti M; Garcia-Garcia R; Balzano T; Taoro L; Felipo V
    Neurochem Int; 2015 Sep; 88():15-9. PubMed ID: 25447766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circling ci2 rat mutant revisited: receptor architecture of the motor cortex.
    Palomero-Gallagher N; Schleicher A; Zilles K; Löscher W
    Neuroscience; 2010 Oct; 170(2):542-50. PubMed ID: 20674682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy.
    Cuilleret G; Pomier-Layrargues G; Pons F; Cadilhac J; Michel H
    Gut; 1980 Jul; 21(7):565-9. PubMed ID: 6776015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

  • 17. Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver.
    Dodd PR; Thomas GJ; Harper CG; Kril JJ
    J Neurochem; 1992 Oct; 59(4):1506-15. PubMed ID: 1328522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminar distribution of neurotransmitter receptors in different reeler mouse brain regions.
    Cremer CM; Lübke JH; Palomero-Gallagher N; Zilles K
    Brain Struct Funct; 2011 Sep; 216(3):201-18. PubMed ID: 21442415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.